Andrew J. Tofe

497 total citations
11 papers, 362 citations indexed

About

Andrew J. Tofe is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Andrew J. Tofe has authored 11 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Andrew J. Tofe's work include Radiopharmaceutical Chemistry and Applications (9 papers), Bone health and treatments (6 papers) and Medical Imaging and Pathology Studies (5 papers). Andrew J. Tofe is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Bone health and treatments (6 papers) and Medical Imaging and Pathology Studies (5 papers). Andrew J. Tofe collaborates with scholars based in United States, Russia and India. Andrew J. Tofe's co-authors include Marion D. Francis, L. Maximilian Buja, Amal Mukherjee, James T. Willerson, Robert W. Parkey, Frederick J. Bonte, Padmakar V. Kulkarni, John A. Bevan, Michael D. Rohrer and Shankar Vallabhajosula and has published in prestigious journals such as Journal of Clinical Investigation, Calcified Tissue International and Implant Dentistry.

In The Last Decade

Andrew J. Tofe

11 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew J. Tofe United States 9 201 111 95 65 62 11 362
A.J.W. Hilson United Kingdom 8 120 0.6× 95 0.9× 161 1.7× 28 0.4× 25 0.4× 19 310
Maurissa Gionet United States 7 311 1.5× 207 1.9× 135 1.4× 235 3.6× 55 0.9× 10 587
Hidekazu Oshima Japan 8 243 1.2× 305 2.7× 119 1.3× 41 0.6× 34 0.5× 20 475
S Nakata Japan 9 194 1.0× 171 1.5× 191 2.0× 13 0.2× 55 0.9× 39 458
Hideyuki Ishijima Japan 7 134 0.7× 76 0.7× 178 1.9× 19 0.3× 49 0.8× 11 391
F. Eugene Holly United States 11 137 0.7× 119 1.1× 182 1.9× 16 0.2× 41 0.7× 17 452
Zehra Özcan Türkiye 11 94 0.5× 85 0.8× 80 0.8× 16 0.2× 58 0.9× 33 327
Joseph Gelbfish United States 6 136 0.7× 309 2.8× 101 1.1× 243 3.7× 25 0.4× 8 443
Benjamin King United States 10 116 0.6× 98 0.9× 128 1.3× 191 2.9× 25 0.4× 29 467
Steven L. Edell United States 10 130 0.6× 114 1.0× 128 1.3× 7 0.1× 55 0.9× 17 394

Countries citing papers authored by Andrew J. Tofe

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Tofe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Tofe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Tofe more than expected).

Fields of papers citing papers by Andrew J. Tofe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Tofe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Tofe. The network helps show where Andrew J. Tofe may publish in the future.

Co-authorship network of co-authors of Andrew J. Tofe

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Tofe. A scholar is included among the top collaborators of Andrew J. Tofe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Tofe. Andrew J. Tofe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hahn, Jack, Michael D. Rohrer, & Andrew J. Tofe. (2003). Clinical, Radiographic, Histologic, and Histomorphometric Comparison of PepGen P-15 Particulate and PepGen P-15 Flow in Extraction Sockets: A Same-Mouth Case Study. Implant Dentistry. 12(2). 170–174. 23 indexed citations
2.
Chinol, Marco, Shankar Vallabhajosula, Stanley J. Goldsmith, et al.. (1993). Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.. PubMed. 34(9). 1536–42. 80 indexed citations
3.
Francis, Marion D., et al.. (1981). Inorganic tin: Chemistry, disposition and role in nuclear medicine diagnostic skeletal imaging agents. International Journal of Nuclear Medicine and Biology. 8(2-3). 145–152. 19 indexed citations
4.
Bevan, John A., Andrew J. Tofe, James J. Benedict, Marion D. Francis, & B.L. Barnett. (1980). Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.. PubMed. 21(10). 961–6. 29 indexed citations
5.
Tofe, Andrew J., John A. Bevan, Mahdi B. Fawzi, et al.. (1980). Gentisic acid: a new stabilizer for low tin skeletal imaging agents: concise communication.. PubMed. 21(4). 366–70. 12 indexed citations
6.
Francis, Marion D., et al.. (1980). DIPHOSPHONATE TREATMENT OF A PRIMARY OSTEOSARCOMA IN A DOG: A CASE REPORT. Veterinary Radiology. 21(4). 168–176. 2 indexed citations
7.
Tofe, Andrew J., et al.. (1979). Synthesis of osseous specific 32P‐labeled disodium ethane‐1‐hydroxy‐1,1‐diphosphonate. Journal of Labelled Compounds and Radiopharmaceuticals. 16(3). 483–493. 1 indexed citations
8.
Potsaid, Majic S., Robert J. Irwin, Frank P. Castronovo, et al.. (1978). [32P] diphosphonate dose determination in patients with bone metastases from prostatic carcinoma.. PubMed. 19(1). 98–104. 18 indexed citations
9.
Buja, L. Maximilian, Andrew J. Tofe, Padmakar V. Kulkarni, et al.. (1977). Sites and Mechanisms of Localization of Technetium-99m Phosphorus Radiopharmaceuticals in Acute Myocardial Infarcts and other Tissues. Journal of Clinical Investigation. 60(3). 724–740. 148 indexed citations
10.
Tofe, Andrew J. & Marion D. Francis. (1976). In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.. PubMed. 17(9). 820–5. 12 indexed citations
11.
Francis, Marion D., et al.. (1976). Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues. Calcified Tissue International. 20(1). 303–311. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026